Can Diovan (valsartan) cause changes in taste in a patient with a history of cardiovascular disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diovan and Taste Changes

Diovan (valsartan) does not cause taste changes. Taste disturbances are a recognized side effect of ACE inhibitors, but not of angiotensin receptor blockers (ARBs) like valsartan 1.

Key Distinction Between Drug Classes

  • ACE inhibitors are associated with taste disturbances, along with their well-known side effect of dry cough 1
  • ARBs like valsartan do not typically cause taste alterations and have a more favorable tolerability profile compared to ACE inhibitors, with significantly lower incidence of cough and only rare reports of angioedema 2

Actual Adverse Effects to Monitor with Valsartan

When prescribing valsartan for patients with cardiovascular disease, focus monitoring on the following established adverse effects:

Hypotension

  • Monitor blood pressure regularly, particularly in elderly patients or those on sacubitril/valsartan formulations 1
  • Watch for symptomatic hypotension, especially after initiation or dose increases 3

Hyperkalemia

  • Check serum potassium levels, particularly in patients with chronic kidney disease or those on other RAAS blockers 1
  • Risk increases with concurrent use of potassium-sparing diuretics, NSAIDs, or other RAAS inhibitors 3

Renal Function Changes

  • Monitor creatinine and estimated glomerular filtration rate (eGFR) 1
  • Valsartan can increase the risk of acute kidney injury, particularly in older adults 3

Clinical Pitfall to Avoid

In patients with cardiovascular disease taking multiple medications, if taste changes occur, look elsewhere for the cause 1. Common culprits include:

  • Certain antiarrhythmic drugs (particularly Class IA agents cause dry mouth) 3
  • Other cardiovascular medications
  • Underlying conditions

The adverse effect profile of valsartan in clinical trials showed events similar to placebo, confirming its excellent tolerability 2.

References

Guideline

Valsartan Adverse Effects and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can Diovan (valsartan) cause taste changes in a patient with a history of cardiovascular disease and potential use of other medications like Zetia (ezetimibe)?
What are the effects and management strategies for a patient with hypertension and possible heart failure taking Co-diovan (Valsartan/Hydrochlorothiazide)?
What is the typical dosage and usage of Diovan (valsartan) for treating high blood pressure or heart failure?
Can I give Dextromethorphan + Guaifenesin (cough suppressant and expectorant) to a patient with Hypertension (HTN) who is on Valsartan (angiotensin II receptor antagonist)?
Can Valsartan (valsartan) reduce chronic elevated troponin levels?
Is it safe to intubate a 79-year-old patient with multiple comorbidities and severe traumatic brain injury using propofol (a hypnotic agent) and midazolam (a benzodiazepine) as pre-intubation medications?
Is a cosyntropin (adrenocorticotropic hormone) stimulation test necessary for a 33-year-old woman with a history of pituitary microadenoma and Hashimoto's antibodies, presenting with hypotension, significant weight loss, fatigue, nausea, cold intolerance, and an inappropriately low adrenocorticotropic hormone (ACTH) level of 10.2, given her indeterminate morning cortisol level?
What precautions should be taken in older adults with cardiovascular disease and possibly osteoporosis, taking diuretics and warfarin, who are at high risk of bone cement implantation syndrome (BCIS)?
What is the appropriate use and dosage of Levodroproprizine for a patient with a dry, irritating cough?
What is the appropriate management for a young to middle-aged adult patient with a low-grade squamous intraepithelial lesion (LSIL) and a history of human papillomavirus (HPV) infection?
What is the treatment for pulmonary fibrosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.